PROFESSOR PADDY STONE MA MD FRCP - Head of the Marie Curie Palliative Care research department at UCL and honorary consultant in palliative medicine at University College London Hospitals NHS Trust

Paddy leads a team undertaking research in two broad domains; end of life care (symptom control, prognostication, communication and sedation) and the palliative care needs of “seldom heard” groups (e.g. patients with dementia, patients with liver cirrhosis, patients with COPD and the homeless). His personal research interests include the mechanisms and management of cancer-related fatigue, prognostication in advanced cancer and quality of life and symptom assessment. He is the Chief Investigator on the Prognosis in Palliative care Study II (PiPS2), and on the Methylphenidate versus placebo for fatigue in advanced cancer (MePFAC) trial, a multicenter placebo-controlled RCT, funded by NIHR HTA.

THE TOPIC WILL INCLUDE:
• The role prognostic information and communication play in reducing the prevalence of burdensome treatments at the end of life
• Prognostic algorithms, prognostic accuracy, and clinical predictions in Palliative Care
• Recommendations on prognostic communication and future research directions

свернуть